Matches 1 - 19 out of 19


Match Document Document Title
US20120027811 Formulations of Viable Cells for Oral Delivery  
This invention relates to solid formulations for the oral delivery of live microbial cells which comprise dried viable cells and small amounts of a bile acid binding agent, for example, an anion...
US20070212325 Insulin Resistance-Improving Agent  
A medicament comprising a pharmaceutically acceptable anion exchange resin as an active ingredient is provided which exhibits an insulin resistance-improving action regardless of volume of meal or...
US20100272671 Co-Therapy For Diabetic Conditions  
Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also...
US20060051314 Drug for prevention and/or treatment of constipation and sympton caused by constipation  
A medicament for preventive and/or therapeutic treatment of constipation and/or a symptom resulting from constipation which comprises magnesium polycarbophil as an active ingredient. The...
US20100021415 COSMETIC USE OF ORGANIC RESINATES  
A cosmetic method for releasing an active principle in a controlled fashion to uninjured skin, as a function of the ion content in or on skin, by exchange with the ions, in order to provide at...
US20070025953 Co-therapy for diabetic conditions  
Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are...
US20100055066 Agent for prophylactic and/or therapeutic treatment of diabetes  
According to the present invention, an agent for prophylactic and/or therapeutic treatment of diabetes comprising a substance inhibiting activity of farnesoid X receptor as an active ingredient...
US20080279808 2,3,4,5-Tetrahydroxy-6-Sulfooxy Hexanoic Acid, Pharmaceutically Acceptable Salts and Equilibrium Forms Thereof, Processes for Their Preparation, Pharmaceutical Compositions Comprising Such Compounds and Their Medical Use  
The invention relates to novel compounds of general formula I wherein M represents hydrogen, or a metallic cation, preferably an alkaline metal, or alkaline-earth metal, and n is equal to 1, 2 or...
US20090004133 Methods and compositions for phosphate binding  
The present invention provides improved methods and compositions for therapeutically controlling and/or reducing serum phosphate levels in animals and mammalian patients. The methods comprise...
US20060251611 Antibacterial processing of fiber products  
The invention provides an antibacterial processing agent for a fiber product comprising an inorganic antibacterial agent comprising an antibacterial metal carried on an inorganic carrier, The...
US20060263327 Method for the production of a stable injectable formulation made of difficult to dissolve antineoplastic active substances  
The invention relates to a method for the production of a stable injectable formulation of antineoplastic active substances which are difficult to dissolve. A formulation containing the...
US20050220755 Topical composition based on ion-exchange resins, in particular for treating erythemas  
The object of the invention is a topical composition particularly for the treatment of erythema, characterized in that it includes at least one ion exchange resin such as colestyramine and at...
US20060083711 Methods and products related to the intracellular delivery of polysaccharides  
The invention relates, in part, to methods and compositions for the intracellular delivery of polysaccharides. In particular, the methods and compositions relate to the intracellular delivery of...
US20060177414 Pharmaceutical preparations for oral adminstration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents  
The present invention relates to pharmaceutical preparations for oral administration, comprising one or more active substances bound to an ion exchanger. In order to improve physical stability and...
US20070110707 Method of treating diseases involving non-enzymatic glycation  
Methods for preventing or diminishing non-enzymatic glycation as well as methods for treating diseases involving non-enzymatic glycation are disclosed. The methods involve administering to a...
US20100129309 AMINE POLYMER COMPOSITIONS  
A pharmaceutical composition for treating hyperphosphatemia can include polymers derived from multi-amine monomers and multifunctional monomers, where the multifunctional monomer includes more...
US20050074424 Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method  
A compound and method are provided for combining a chemotherapeutic drug with a polyion polymer for selective chemotherapy delivery. A glucose solution is combined with the polyion polymer, which...
US20050265955 Sustained release preparations  
Disclosed are sustained release drug particles suitable for forming sustained release oral pharmaceutical compositions. The sustained release drug particles comprise a drug-ion exchange resin...
US20100233116 ORGANIC COMPOUNDS  
The present invention provides heterocyclic derivatives hat modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase...

Matches 1 - 19 out of 19